Revenue Summary of Luoxin Pharmaceuticals Group Stock Co., Ltd.

Luoxin Pharmaceuticals Group Stock Co., Ltd.'s latest annual revenue in 2023 was 2.34 Billion CNY , down -34.7% from previous year.
Luoxin Pharmaceuticals Group Stock Co., Ltd.'s latest quarterly revenue in 2024 Q3 was 617.57 Million CNY , up 8.97% from previous quarter.
Luoxin Pharmaceuticals Group Stock Co., Ltd. reported a annual revenue of 3.58 Billion CNY in annual revenue 2022, down -44.62% from previous year.
Luoxin Pharmaceuticals Group Stock Co., Ltd. reported a annual revenue of 6.47 Billion CNY in annual revenue 2021, up 6.27% from previous year.
Luoxin Pharmaceuticals Group Stock Co., Ltd. reported a quarterly revenue of 683.69 Million CNY for 2024 Q1, up 28.93% from previous quarter.
Luoxin Pharmaceuticals Group Stock Co., Ltd. reported a quarterly revenue of 570.5 Million CNY for 2024 Q2, down -16.56% from previous quarter.

Annual Revenue Chart of Luoxin Pharmaceuticals Group Stock Co., Ltd. (2023 - 2011)

Historical Annual Revenue of Luoxin Pharmaceuticals Group Stock Co., Ltd. (2023 - 2011)

Year	Revenue	Revenue Growth
2023	2.34 Billion CNY	-34.7%
2022	3.58 Billion CNY	-44.62%
2021	6.47 Billion CNY	6.27%
2020	6.09 Billion CNY	-19.67%
2019	7.58 Billion CNY	711.25%
2018	935.44 Million CNY	12.97%
2017	828.04 Million CNY	29.91%
2016	637.39 Million CNY	9.1%
2015	584.21 Million CNY	8.73%
2014	537.32 Million CNY	13.32%
2013	474.17 Million CNY	-0.1%
2012	474.63 Million CNY	12.09%
2011	423.42 Million CNY	0.0%

Year	Revenue	Revenue Growth
2024 Q3	617.57 Million CNY	8.97%
2024 Q1	683.69 Million CNY	28.93%
2024 Q2	570.5 Million CNY	-16.56%
2023 Q4	530.27 Million CNY	-7.14%
2023 Q2	593.02 Million CNY	-10.48%
2023 FY	2.34 Billion CNY	-34.7%
2023 Q1	662.42 Million CNY	463.83%
2023 Q3	571.05 Million CNY	-3.71%
2022 Q3	626.81 Million CNY	-35.09%
2022 Q2	965.73 Million CNY	-55.64%
2022 Q1	2.17 Billion CNY	57.16%
2022 FY	3.58 Billion CNY	-44.62%
2022 Q4	-182.07 Million CNY	-129.05%
2021 FY	6.47 Billion CNY	6.27%
2021 Q2	1.7 Billion CNY	-2.37%
2021 Q1	1.74 Billion CNY	0.31%
2021 Q3	1.64 Billion CNY	-3.05%
2021 Q4	1.38 Billion CNY	-16.0%
2020 Q1	1.27 Billion CNY	-81.2%
2020 Q2	1.4 Billion CNY	10.11%
2020 Q4	1.73 Billion CNY	3.42%
2020 FY	6.09 Billion CNY	-19.67%
2020 Q3	1.67 Billion CNY	19.59%
2019 Q4	6.78 Billion CNY	2465.86%
2019 FY	7.58 Billion CNY	711.25%
2019 Q2	293.66 Million CNY	18.56%
2019 Q1	247.69 Million CNY	-9.96%
2019 Q3	264.35 Million CNY	-9.98%
2018 Q1	195.96 Million CNY	-3.29%
2018 FY	935.44 Million CNY	12.97%
2018 Q3	198.63 Million CNY	-25.25%
2018 Q4	275.09 Million CNY	38.49%
2018 Q2	265.74 Million CNY	35.61%
2017 Q2	243.07 Million CNY	27.9%
2017 FY	828.04 Million CNY	29.91%
2017 Q4	202.63 Million CNY	5.38%
2017 Q1	190.04 Million CNY	25.32%
2017 Q3	192.29 Million CNY	-20.89%
2016 Q2	197.88 Million CNY	40.77%
2016 FY	637.39 Million CNY	9.1%
2016 Q4	151.64 Million CNY	2.96%
2016 Q3	147.28 Million CNY	-25.57%
2016 Q1	140.57 Million CNY	-8.22%
2015 FY	584.21 Million CNY	8.73%
2015 Q3	126.3 Million CNY	-33.4%
2015 Q2	189.65 Million CNY	64.79%
2015 Q4	153.15 Million CNY	21.26%
2015 Q1	115.08 Million CNY	-85.07%
2014 Q4	771.05 Million CNY	17.2%
2014 Q3	657.91 Million CNY	-5.27%
2014 Q1	643.33 Million CNY	-15.46%
2014 FY	537.32 Million CNY	13.32%
2014 Q2	694.49 Million CNY	7.95%
2013 Q3	624.89 Million CNY	19.02%
2013 Q4	761 Million CNY	21.78%
2013 Q2	525.02 Million CNY	-15.12%
2013 Q1	618.53 Million CNY	0.81%
2013 FY	474.17 Million CNY	-0.1%
2012 FY	474.63 Million CNY	12.09%
2012 Q4	613.57 Million CNY	0.63%
2012 Q3	609.7 Million CNY	0.0%
2011 FY	423.42 Million CNY	0.0%

Peer Revenue Comparison of Luoxin Pharmaceuticals Group Stock Co., Ltd.

Name	Revenue	Revenue Difference
Shenzhen Neptunus Bioengineering Co., Ltd.	36.41 Billion CNY	93.568%
Anhui Fengyuan Pharmaceutical Co., Ltd.	4.27 Billion CNY	45.207%
Dong-E-E-Jiao Co.,Ltd.	4.71 Billion CNY	50.318%
Livzon Pharmaceutical Group Inc.	12.27 Billion CNY	80.921%
Hainan Haiyao Co., Ltd.	1.45 Billion CNY	-60.759%
Tus-Pharmaceutical Group Co., Ltd.	395.92 Million CNY	-491.685%
Jilin Aodong Pharmaceutical Group Co., Ltd.	3.44 Billion CNY	32.081%
Changchun High-Tech Industries (Group) Inc.	14.46 Billion CNY	83.799%
Apeloa Pharmaceutical Co.,Ltd	11.47 Billion CNY	79.584%
PKU HealthCare Corp.,Ltd.	2.19 Billion CNY	-6.784%
Chengdu Huasun Technology Group Inc., Ltd.	1 Billion CNY	-133.474%
Dezhan Healthcare Company Limited	498.08 Million CNY	-370.322%
Jinling Pharmaceutical Company Limited	2.78 Billion CNY	15.907%
Jiuzhitang Co., Ltd.	2.91 Billion CNY	19.755%
Huapont Life Sciences Co., Ltd.	11.59 Billion CNY	79.796%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	3.95 Billion CNY	40.725%
Shandong Wohua Pharmaceutical Co., Ltd.	894.31 Million CNY	-161.946%
Hengkang Medical Group Co., Ltd.	3.59 Billion CNY	34.755%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	2.61 Billion CNY	10.263%
Qianjiang Yongan Pharmaceutical Co., Ltd.	962.8 Million CNY	-143.312%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	5.42 Billion CNY	56.792%
Jinhe Biotechnology CO., LTD.	2.17 Billion CNY	-7.75%
Teyi Pharmaceutical Group Co.,Ltd	1.06 Billion CNY	-119.508%
Kunming Longjin Pharmaceutical Co., Ltd.	86.62 Million CNY	-2604.399%
Beijing Aosaikang Pharmaceutical Co., Ltd.	1.44 Billion CNY	-62.292%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	3.95 Billion CNY	40.805%
Anhui Huangshan Capsule Co., Ltd.	458.36 Million CNY	-411.077%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	980.82 Million CNY	-138.841%
Zhuhai Rundu Pharmaceutical Co., Ltd.	1.29 Billion CNY	-81.333%
Huaren Pharmaceutical Co., Ltd.	1.63 Billion CNY	-43.169%
Tianjin Ringpu Bio-Technology Co.,Ltd.	2.24 Billion CNY	-4.164%
Shanxi Zhendong Pharmaceutical Co.,Ltd	3.62 Billion CNY	35.394%
Fuan Pharmaceutical (Group) Co., Ltd.	2.64 Billion CNY	11.524%
Hybio Pharmaceutical Co., Ltd.	431.38 Million CNY	-443.047%
Baotou Dongbao Bio-Tech Co.,Ltd	974.51 Million CNY	-140.389%
Hunan Er-Kang Pharmaceutical Co., Ltd	1.76 Billion CNY	-32.412%
Changjiang Pharmaceutical Group Co., Ltd.	1.19 Billion CNY	-95.616%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	1.09 Billion CNY	-114.006%
Fujian Cosunter Pharmaceutical Co., Ltd.	422.71 Million CNY	-454.184%
Beijing Science Sun Pharmaceutical Co., Ltd.	476.56 Million CNY	-391.559%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	270.39 Million CNY	-766.354%
Hainan Poly Pharm. Co., Ltd	1.3 Billion CNY	-79.582%
Jiangxi Synergy Pharmaceutical Co., Ltd.	722.13 Million CNY	-224.4%
Wuhan Hiteck Biological Pharma Co.,Ltd	602.28 Million CNY	-288.956%
Shandong Xinhua Pharmaceutical Company Limited	8 Billion CNY	70.749%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	2.52 Billion CNY	7.306%
PharmaBlock Sciences (Nanjing), Inc.	1.72 Billion CNY	-35.788%
Jinghua Pharmaceutical Group Co., Ltd.	1.49 Billion CNY	-57.176%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	2.17 Billion CNY	-7.861%
Betta Pharmaceuticals Co., Ltd.	2.45 Billion CNY	4.624%
Tibet AIM Pharm. Inc.	667.03 Million CNY	-251.197%
Shenzhen Kangtai Biological Products Co., Ltd.	3.47 Billion CNY	32.634%
Shandong Shanda Wit Science and Technology Co., Ltd.	2.48 Billion CNY	5.698%
Pacific Shuanglin Bio-pharmacy Co., LTD	2.32 Billion CNY	-0.597%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	1.62 Billion CNY	-44.084%
Xiamen Kingdomway Group Company	3.1 Billion CNY	24.495%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	799.3 Million CNY	-193.082%
Walvax Biotechnology Co., Ltd.	4.11 Billion CNY	43.054%
Sunflower Pharmaceutical Group Co.,Ltd	5.63 Billion CNY	58.404%
Harbin Gloria Pharmaceuticals Co., Ltd	2.58 Billion CNY	9.549%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	24.73 Billion CNY	90.531%
Hunan Hansen Pharmaceutical Co., Ltd.	955.53 Million CNY	-145.164%
Changzhou Qianhong Biopharma CO.,LTD	1.79 Billion CNY	-30.591%
Shenzhen Weiguang Biological Products Co., Ltd.	1.04 Billion CNY	-123.425%
Honz Pharmaceutical Co., Ltd.	739.56 Million CNY	-216.754%
Northeast Pharmaceutical Group Co., Ltd.	8.16 Billion CNY	71.296%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	1.46 Billion CNY	-60.16%
Guizhou Xinbang Pharmaceutical Co., Ltd.	6.46 Billion CNY	63.741%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	1.13 Billion CNY	-107.282%
Zhejiang Yatai Pharmaceutical Co., Ltd.	420.64 Million CNY	-456.913%
Zhejiang NHU Company Ltd.	15.11 Billion CNY	84.503%
ApicHope Pharmaceutical Co., Ltd	2.5 Billion CNY	6.424%
Shanghai Kaibao Pharmaceutical CO.,Ltd	1.59 Billion CNY	-46.96%
Beijing SL Pharmaceutical Co., Ltd.	1.01 Billion CNY	-130.039%
Yunnan Baiyao Group Co.,Ltd	38.9 Billion CNY	93.978%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	1.08 Billion CNY	-116.899%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	839.25 Million CNY	-179.129%
Guangdong Lifestrong Pharmacy Co., Ltd.	292.39 Million CNY	-701.177%
Huadong Medicine Co., Ltd	40.39 Billion CNY	94.2%
Jiangsu Nhwa Pharmaceutical Co., LTD	4.97 Billion CNY	52.898%
Harbin Medisan Pharmaceutical Co., Ltd.	1.18 Billion CNY	-97.392%
LanZhou Foci Pharmaceutical Co.,Ltd.	1.16 Billion CNY	-101.406%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	6.12 Billion CNY	61.767%
Beijing Beilu Pharmaceutical Co., Ltd	890.71 Million CNY	-163.003%
Nanjing Hicin Pharmaceutical Co., Ltd.	517.83 Million CNY	-352.39%
Renhe Pharmacy Co., Ltd.	5.03 Billion CNY	53.447%
Chongqing Pharscin Pharmaceutical Co., Ltd.	691.54 Million CNY	-238.753%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	4.12 Billion CNY	43.187%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	4.26 Billion CNY	45.047%

Global Stocks Search

Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ)

Revenue Summary of Luoxin Pharmaceuticals Group Stock Co., Ltd.

Annual Revenue Chart of Luoxin Pharmaceuticals Group Stock Co., Ltd. (2023 - 2011)

Historical Annual Revenue of Luoxin Pharmaceuticals Group Stock Co., Ltd. (2023 - 2011)

Peer Revenue Comparison of Luoxin Pharmaceuticals Group Stock Co., Ltd.